SYNLAB Ghana has officially responded to media reports concerning a GHC10 million lawsuit filed against the company over alleged inaccurate HIV test results that purportedly caused a female client to lose her job and suffer reputational damage.

In a statement issued on Tuesday, 1st July, SYNLAB confirmed that the matter is currently before the court but firmly rejected the public narrative being circulated, describing it as “inaccurate, misleading, and prejudicial.”

“While we respect the individual’s right to seek legal redress, we strongly reject the narrative being propagated in the media,” the company stated.

SYNLAB Ghana emphasised that it is fully cooperating with the court and has engaged legal counsel to defend its position.

“We have filed a statement of defence denying all the allegations made against the company,” it added.

Addressing public concerns over its testing protocols, SYNLAB reaffirmed its commitment to internationally recognised standards and rigorous quality assurance processes. The company holds certification from Ghana’s Health Facilities Regulatory Agency (HeFRA) and ISO 15189:2022 accreditation through DAkkS, Germany’s national accreditation body.

“Our laboratory follows robust internal and external quality controls to ensure the highest standards of accuracy, integrity, and confidentiality in all diagnostic services, including HIV testing,” the statement said.

SYNLAB further cautioned media outlets and the public against spreading unverified claims, warning that such actions could not only misinform the public but also interfere with judicial proceedings.

“The publication in question is not only unbalanced but also contains factual inaccuracies that we are addressing through the appropriate legal channels,” it stated.

Despite the ongoing litigation, SYNLAB Ghana reassured its clients, partners, and the general public that its services remain unaffected.

“SYNLAB Ghana remains a trusted provider of diagnostic excellence, and this matter in no way affects the quality, accuracy, or reliability of our services,” the company concluded.

The lawsuit has sparked public interest, but SYNLAB has urged all parties to allow the legal process to take its course without prejudice or sensationalism.